top of page
dniven_a_professional_minimalist_photo_realistic_image_of_a_sty_773c2d35-49b4-4205-adfd-38

Clarity and Strategy for Complex Pharma Decisions

Helping life sciences companies shape markets, secure access, and make confident portfolio choices.

dniven_a_professional_minimalist_photo_realistic_image_of_a_s_c610be29-5a97-467f-a3e2-b5d8

What we do

Go-to-Market Strategy

Go-To-Market Strategy

Sharpen launch planning and prepare cross-functional teams

Market Access

Market Access Strategy

Design value stories and evidence plans that secure reimbursement.

Portfolio Optimisation

Prioritise assets and support investment decisions with clarity

What sets us apart

✔ Market-back, insight-led thinking
✔ Deep expertise in complex therapy areas
✔ Flexible, senior engagement
✔ Trusted by biopharma, healthcare and investor companies

dniven_a_professional_minimalist_photo_realistic_image_of_a_sty_7f01bead-a759-4865-bc13-d0

Example projects

US pricing and reimbursement scenarios for biotech's clinical development, regulatory planning, and market viability 

​

Joint Clinical Assessment / Health Technology Assessment planning for oncology companies looking to launch in the EU

​

Business-to-Business go-to-market strategy for a healthcare company with biopharma and health system partners

Our latest thinking

Hear Doug Niven talk with Dr Stefan Walzer on the World’s #2 Health Economics Podcast 
Topic: Can Europe maintain its leadership in Market Access, or is it falling behind?
 
1753434113942.jpeg

Get in Touch

Contact Doug Niven

+34 685 92 39 41

dniven@nivenbiopharma.com

    Thanks for submitting!

    Let’s explore how we could support your next milestone

    ​

    bottom of page